Affiliation:
1. Ural State Medical University, Ministry of Health of Russia, Yekaterinburg
2. Medical Center «Academy of Health», Penza
Abstract
The article presents the results of the positive effect of the drug Cardioton on blood pressure, cardio-pain syndrome by type of cardialgia in patients with hypertension with different daily blood pressure index. It was revealed that Cardiotone relieved cardialgia-type cardio-pain syndrome in 94% of cases. 83% of patients have normalization of blood pressure, 17% have a tendency to decrease blood pressure. After treatment, the hypotensive effect of Cardiotone was observed in all groups of patients, depending on the value of the daily blood pressure index: 90% in dipper patients (with a normal decrease in blood pressure at night), 76% in non-dipper (with insufficient nocturnal decrease in blood pressure), 69% in over-dipper (with excessive decrease in blood pressure at night night time). It should be noted that blood pressure tends to normalize in almost half (43%) of people with the most unfavorable prognosis for the development of CVD with a nocturnal increase in blood pressure (the profile was assessed as night peaker). Cardioton is a natural cardioprotector; strengthens the heart muscle by improving its oxygen supply, relieves inflammatory processes in the myocardium; has antihypertensive, anti-ischemic, cardiometabolic effects. It is recommended for disorders of the cardiovascular system, with increased physical exertion. Based on the conducted research, it can be concluded that Cardiotone is well tolerated by patients and is an effective treatment
Publisher
Russian Vrach, Publishing House Ltd.
Reference28 articles.
1. Румянцева С.А., Ступин В.А. и др. Теория и практика лечения больных с сосудистой коморбидностью. Клиническое руководство. М., СПб: Международная издательская группа «Мед. книга», 2013; 360 с. [Rumyantseva S.A., Stupin V.A. and others. Theory and practice of treatment of patients with vascular comorbidity. Clinical management. M., St. Petersburg: International publishing group «Med. Kniga», 2013; 360 c. (in Russ.)].
2. Кобалава Ж.Д., Котовская Ю.В. Мониторирование артериального давления: методические аспекты и клиническое применение. М., 2009; с. 72 [Kobalava J.D., Kotovskaya Y.V. Blood pressure monitoring: methodological aspects and clinical application. M., 2009; p.72 (in Russ.)].
3. Хабибулина М.М. Кардиоваскулярный риск при эстрогенодефиците в доклимактрических периодах. Монография. Екатеринбург, 2014; 193 с. [Khabibulina M.M. Cardiovascular risk in estrogen deficiency in preclimactric periods. Monograph. Yekaterinburg, 2014; 193 р. (in Russ.)].
4. Ларина В.Н., Карпенко Д.Г. Метаболическая и цитопротективная направленность мельдония на фоне мультиморбидности. Врач. 2022; 33 (4): 56–62 [Larina V., Karpenko D. The metabolic and cytoprotective orientation of meldonium in multimorbidity. Vrach. 2022; 33 (4): 56–62 (in Russ.)]. DOI: 10.29296/25877305-2022-04-08
5. Хмельницкий А., Прощаев К., Елистратов Д. Особенности нейроиммуноэндокринного и гериатрического статусов у пациентов с ишемической болезнью сердца, которым показано плановое аортокоронарное шунтирование. Врач. 2019; 30 (7): 46–9 [Khmelnitsky А., Prashchayeu К., Elistratov D. The features of neuroimmune endocrine and geriatric status in patients with coronary artery disease scheduled coronary artery bypass surgery. Vrach. 2019; 30 (7): 46–9 (in Russ.)] DOI: 10.29296/25877305-2019-07-09